ArticleCells2021

Generation and Evaluation of Isogenic iPSC as a Source of Cell Replacement Therapies in Patients with Kearns Sayre Syndrome.

Glen Lester Sequiera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.